---
title: "Linzess (linaclotide) in irritable bowel syndrome with constipation: Dosing and administration questions"
description: "Dosing and administration questions on Linzess (linaclotide) in irritable bowel syndrome with constipation, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Dosing. Questions: What is the Linzess dose for IBS-C? Does a Linzess dose above 145 mcg help children with IBS-C? 2 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/linzess--irritable-bowel-syndrome-with-constipation/dosing-and-administration"
published: "2026-11-14T00:11:41-05:00"
modified: "2026-11-14T01:54:55-05:00"
---

# Linzess (linaclotide) in irritable bowel syndrome with constipation: Dosing and administration questions

Manufacturer: AbbVie, Inc.; Ironwood Pharmaceuticals, Inc.  
Prescribing information: [Linzess](https://www.rxabbvie.com/pdf/linzess_pi.pdf)

Dosing and administration questions that apply to every indication of Linzess are on [Linzess (linaclotide), all indications: Dosing and administration](https://www.evicenter.com/medical-information/linzess/dosing-and-administration).

## Dosing

<a id="linzess-ibs-c-dose"></a>

### What is the Linzess dose for IBS-C?

> “Irritable Bowel Syndrome with Constipation (IBS-C): 
>
> The recommended dosage of LINZESS is: 
> • Adults: 290 mcg orally once daily 
> • Pediatric patients 7 years of age and older: 145 mcg orally once daily”

Source: [LINZESS: Prescribing information, page 2, captured 2026-11-14](https://www.rxabbvie.com/pdf/linzess_pi.pdf#page=2)

<a id="linzess-pediatric-higher-dose"></a>

### Does a Linzess dose above 145 mcg help children with IBS-C?

Applies to: Irritable bowel syndrome with constipation (IBS-C) in pediatric patients 7 years of age and older

> “A total of 108 patients were randomized to receive treatment with 
> LINZESS 145 mcg once daily or a higher than recommended dosage of LINZESS. The higher 
> LINZESS dosage group did not demonstrate additional treatment benefit compared to 
> LINZESS 145 mcg once daily.”

Source: [LINZESS: Prescribing information, page 19, captured 2026-11-14](https://www.rxabbvie.com/pdf/linzess_pi.pdf#page=19)

> “Severe diarrhea occurred in 1 pediatric patient with IBS-C treated with LINZESS at a higher dose than the recommended 145 mcg once-daily dosage.<sup>1</sup>”

Source: [LINZESS: pediatric-ibs-c-safety, captured 2026-11-14](https://www.linzesshcp.com/pediatric-ibs-c-safety#:~:text=Severe%20diarrhea%20occurred%20in%201,the%20recommended%20145%20mcg%20once%2Ddaily)

> “• In a double-blind trial of patients 7 to 17 years of age with IBS-C, diarrhea was reported 
> in 7% and 8% of patients treated with LINZESS 145 mcg and 290 mcg once daily, 
> respectively.”

Source: [LINZESS: Prescribing information, page 4, captured 2026-11-14](https://www.rxabbvie.com/pdf/linzess_pi.pdf#page=4)

## Related pages
- [Medical information: Linzess (linaclotide): Irritable bowel syndrome with constipation](https://www.evicenter.com/medical-information/linzess--irritable-bowel-syndrome-with-constipation)
- [Clinical trials](https://www.evicenter.com/medical-information/linzess--irritable-bowel-syndrome-with-constipation/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/linzess--irritable-bowel-syndrome-with-constipation/safety)
- [Specific populations](https://www.evicenter.com/medical-information/linzess--irritable-bowel-syndrome-with-constipation/specific-populations)
- [Guidelines](https://www.evicenter.com/medical-information/linzess--irritable-bowel-syndrome-with-constipation/guidelines)
